David Happel

2022

In 2022, David Happel earned a total compensation of $6.5M as President and Chief Executive Officer at Sagimet Biosciences.

Compensation breakdown

Non-Equity Incentive Plan$211,500
Option Awards$6,198,479
Salary$97,917
Other$297
Total$6,508,193

Happel received $6.2M in option awards, accounting for 95% of the total pay in 2022.

Happel also received $211.5K in non-equity incentive plan, $97.9K in salary and $297 in other compensation.

Rankings

In 2022, David Happel's compensation ranked 451st out of 5,753 executives tracked by ExecPay. In other words, Happel earned more than 92.2% of executives.

ClassificationRankingPercentile
All
451
out of 5,753
92nd
Division
Manufacturing
187
out of 3,133
94th
Major group
Chemicals And Allied Products
49
out of 1,419
97th
Industry group
Drugs
37
out of 1,320
97th
Industry
Pharmaceutical Preparations
24
out of 966
98th
Source: SEC filing on April 18, 2024.

Happel's colleagues

We found three more compensation records of executives who worked with David Happel at Sagimet Biosciences in 2022.

2022

George Kemble

Sagimet Biosciences

Chief Executive Officer

2022

Eduardo Martins

Sagimet Biosciences

Chief Medical Officer

2022

Dennis Hom

Sagimet Biosciences

Chief Financial Officer

News

In-depth

You may also like